These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15018832)

  • 1. AMPA receptor modulators as cognitive enhancers.
    Lynch G
    Curr Opin Pharmacol; 2004 Feb; 4(1):4-11. PubMed ID: 15018832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMPA receptor potentiators as cognitive enhancers.
    O'Neill MJ; Dix S
    IDrugs; 2007 Mar; 10(3):185-92. PubMed ID: 17351873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in positive allosteric modulators of the AMPA receptor.
    Morrow JA; Maclean JK; Jamieson C
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):571-9. PubMed ID: 17002217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [AMPA receptor desensitization and fast excitatory synaptic transmission].
    Lu T; Yang XL
    Sheng Li Ke Xue Jin Zhan; 1997 Jul; 28(3):197-202. PubMed ID: 11038724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
    Ryder JW; Falcone JF; Manro JR; Svensson KA; Merchant KM
    J Pharmacol Exp Ther; 2006 Oct; 319(1):293-8. PubMed ID: 16803862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors.
    Suppiramaniam V; Bahr BA; Sinnarajah S; Owens K; Rogers G; Yilma S; Vodyanoy V
    Synapse; 2001 May; 40(2):154-8. PubMed ID: 11252027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AMPA receptors in synaptic plasticity.
    Sprengel R
    Cell Tissue Res; 2006 Nov; 326(2):447-55. PubMed ID: 16896950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors.
    Shemer I; Holmgren C; Min R; Fülöp L; Zilberter M; Sousa KM; Farkas T; Härtig W; Penke B; Burnashev N; Tanila H; Zilberter Y; Harkany T
    Eur J Neurosci; 2006 Apr; 23(8):2035-47. PubMed ID: 16630051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating excitatory synaptic neurotransmission: potential treatment for neurological disease?
    Yamada KA
    Neurobiol Dis; 1998 Aug; 5(2):67-80. PubMed ID: 9746904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Allosteric modulators of AMPA type glutamate receptors a novel gubclass of physiologically active substances].
    Raevskiĭ KS; Eremin KO
    Biomed Khim; 2004; 50(6):523-38. PubMed ID: 15707268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory mechanisms of AMPA receptors in synaptic plasticity.
    Derkach VA; Oh MC; Guire ES; Soderling TR
    Nat Rev Neurosci; 2007 Feb; 8(2):101-13. PubMed ID: 17237803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of ketamine-induced working memory impairments by AMPA potentiators in a nonhuman primate model of cognitive dysfunction.
    Roberts BM; Holden DE; Shaffer CL; Seymour PA; Menniti FS; Schmidt CJ; Williams GV; Castner SA
    Behav Brain Res; 2010 Sep; 212(1):41-8. PubMed ID: 20347881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutamate-based therapeutic approaches: ampakines.
    Lynch G
    Curr Opin Pharmacol; 2006 Feb; 6(1):82-8. PubMed ID: 16361116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AMPA receptor modulators have different impact on hippocampal pyramidal cells and interneurons.
    Xia YF; Arai AC
    Neuroscience; 2005; 135(2):555-67. PubMed ID: 16125852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating effects of preadolescent aniracetam treatment on prenatal ethanol-induced impairment in AMPA receptor activity.
    Wijayawardhane N; Shonesy BC; Vaithianathan T; Pandiella N; Vaglenova J; Breese CR; Dityatev A; Suppiramaniam V
    Neurobiol Dis; 2008 Jan; 29(1):81-91. PubMed ID: 17916430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPA receptor regulation mechanisms: future target for safer neuroprotective drugs.
    Jayakar SS; Dikshit M
    Int J Neurosci; 2004 Jun; 114(6):695-734. PubMed ID: 15204061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xenon reduces N-methyl-D-aspartate and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor-mediated synaptic transmission in the amygdala.
    Haseneder R; Kratzer S; Kochs E; Eckle VS; Zieglgänsberger W; Rammes G
    Anesthesiology; 2008 Dec; 109(6):998-1006. PubMed ID: 19034096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Xenon attenuates excitatory synaptic transmission in the rodent prefrontal cortex and spinal cord dorsal horn.
    Haseneder R; Kratzer S; Kochs E; Mattusch C; Eder M; Rammes G
    Anesthesiology; 2009 Dec; 111(6):1297-307. PubMed ID: 19934875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postnatal aniracetam treatment improves prenatal ethanol induced attenuation of AMPA receptor-mediated synaptic transmission.
    Wijayawardhane N; Shonesy BC; Vaglenova J; Vaithianathan T; Carpenter M; Breese CR; Dityatev A; Suppiramaniam V
    Neurobiol Dis; 2007 Jun; 26(3):696-706. PubMed ID: 17493826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of the purinoceptor antagonists suramin and pyridoxal-5'-phosphate-6-(2'-naphthylazo-6'-nitro-4',8'-disulfonate) (PPNDS) on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors.
    Suzuki E; Kessler M; Montgomery K; Arai AC
    Mol Pharmacol; 2004 Dec; 66(6):1738-47. PubMed ID: 15448189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.